Investors with a lot of money to spend have taken a bearish stance on Alnylam Pharmaceuticals ALNY.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ALNY, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 15 uncommon options trades for Alnylam Pharmaceuticals.
This isn't normal.
The overall sentiment of these big-money traders is split between 26% bullish and 66%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $846,993, and 8 are calls, for a total amount of $339,335.
Expected Price Movements
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $125.0 to $200.0 for Alnylam Pharmaceuticals during the past quarter.
Volume & Open Interest Trends
In terms of liquidity and interest, the mean open interest for Alnylam Pharmaceuticals options trades today is 742.33 with a total volume of 1,150.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Alnylam Pharmaceuticals's big money trades within a strike price range of $125.0 to $200.0 over the last 30 days.
Alnylam Pharmaceuticals 30-Day Option Volume & Interest Snapshot
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | PUT | SWEEP | BEARISH | 07/19/24 | $21.7 | $19.7 | $21.5 | $150.00 | $227.9K | 2.0K | 2 |
| ALNY | PUT | SWEEP | BEARISH | 07/19/24 | $17.9 | $15.5 | $17.9 | $140.00 | $223.7K | 571 | 0 |
| ALNY | PUT | TRADE | BULLISH | 08/16/24 | $26.1 | $23.6 | $23.6 | $155.00 | $118.0K | 112 | 0 |
| ALNY | PUT | SWEEP | BULLISH | 07/19/24 | $13.5 | $10.9 | $10.9 | $125.00 | $109.0K | 711 | 109 |
| ALNY | PUT | SWEEP | BULLISH | 07/19/24 | $13.5 | $9.9 | $10.7 | $125.00 | $107.0K | 711 | 209 |
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
Current Position of Alnylam Pharmaceuticals
- With a volume of 329,711, the price of ALNY is up 2.91% at $161.97.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 41 days.
What The Experts Say On Alnylam Pharmaceuticals
1 market experts have recently issued ratings for this stock, with a consensus target price of $283.0.
- Consistent in their evaluation, an analyst from Canaccord Genuity keeps a Buy rating on Alnylam Pharmaceuticals with a target price of $283.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Alnylam Pharmaceuticals with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
